Skip to Content

Fluciclovine F 18 Side Effects

Medically reviewed by Last updated on Oct 14, 2020.

For the Consumer

Applies to fluciclovine F 18: intravenous solution

Side effects requiring immediate medical attention

Along with its needed effects, fluciclovine F 18 may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking fluciclovine F 18:

Incidence not known

  • Cough
  • difficulty with swallowing
  • dizziness
  • fast heartbeat
  • hives, itching, or skin rash
  • puffiness or swelling of the eyelids or around the eyes, face, lips, throat, or tongue
  • tightness in the chest
  • trouble breathing
  • unusual tiredness or weakness

Side effects not requiring immediate medical attention

Some side effects of fluciclovine F 18 may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


  • Change in taste
  • loss of taste
  • redness or pain at the injection site

For Healthcare Professionals

Applies to fluciclovine F 18: intravenous solution


Uncommon (0.1% to 1%): Injection site pain, injection site erythema[Ref]

Nervous system

Uncommon (0.1% to 1%): Dysgeusia[Ref]


1. "Product Information. Axumin (fluciclovine F-18)." Blue Earth Diagnostics Inc., Burlington , MA.

More about fluciclovine F 18

Consumer resources

Other brands

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.